Iodine-131 metaiodobenzylguanidine (I-131 MIBG)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Iodine-131 metaiodobenzylguanidine (I-131 MIBG), covering 2013-07-10 to 2013-07-10. Get the full timeline:
Most recent: Clinical Trial Update: High-Dose Iodine I 131 Metaiodobenzylguanidine, Topotecan, and Peripheral Stem Cell Transplant in Treating Young Patients With Relapsed Stage 4 Neuroblastoma or Primary Resistant High-Risk Neuroblastoma [Phase 2]